ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Spyre Therapeutics Inc

Spyre Therapeutics Inc (SYRE)

23.86
0.73
(3.16%)
Closed December 20 4:00PM
23.86
0.00
( 0.00% )
Pre Market: 5:49AM

Spyre Therapeutics Inc Financial Summary

The current SYRE market cap is 1.23B. The company's latest EPS is USD -6.5872 and P/E is -3.62.

Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 00000
Operating Income -32.95M-47.75M-47.77M-44.15M-55.39M
Net Income -40.16M-63.13M-43.86M-38.84M-69.03M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Revenue 0018.74M2.33M886k
Operating Income -80.33M-81.48M-65.65M-84.78M-258.75M
Net Income -78.25M-80.89M-65.8M-83.82M-338.79M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 207.27M341.86M487.6M436.07M421.09M
Total Liabilities 65.56M73.29M81.93M61.68M93.7M
Total Equity -245.4M184.02M152.27M374.39M327.39M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Total Assets 83.18M161.62M109.93M71.14M341.86M
Total Liabilities 23.1M21.79M25.99M20.84M73.29M
Total Equity 60.08M139.83M83.94M50.31M184.02M
Quarter End Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -68.87M-99.91M-28.54M-90.79M-120.21M
Investing -73.12M-108.39M-104.96M-225.48M-182.74M
Financing 197.47M361.08M172.17M172.53M185.31M
Year End December 30 2023 20192020202120222023
USD ($)USD ($)USD ($)USD ($)USD ($)
Operating -65.69M-75.78M-53.72M-80.14M-99.91M
Investing -1.74M-7.6M-22.62M57.01M-108.39M
Financing 65.72M154.51M1.39M42.68M361.08M
Market Cap 1.23B
Price to Earnings Ratio -3.62
Price to Sales Ratio 1.39k
Price to Cash Ratio 6.5
Price to Book Ratio 4.57
Dividend Yield -

Share Statistics

Shares Outstanding 51.43M
Average Volume (1 week) 688.2k
Average Volume (1 Month) 555.49k
52 Week Change 31.75%
52 Week High 47.97
52 Week Low 17.83
Spread (Intraday) 16.17 (42.36%)

Company Info

Company Name Spyre Therapeutics Inc
Address 1521 concord pike
wilmington, delaware 19803
Website https://www.spyre.com
Industry pharmaceutical preparations (2834)

Your Recent History

Delayed Upgrade Clock